1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.2337/db25-1604-p
Abstract: Introduction and Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with “at-risk” MASH (steatohepatitis with significant fibrosis stage ≥F2) and cirrhosis. Magnetic resonance (MR) iron-corrected T1 mapping (cT1) allows for improved MASH risk stratification,… read more here.
Keywords: none; dysfunction; mmash; mash ... See more keywords